metformin has been researched along with Cancer Pain in 1 studies
Metformin: A biguanide hypoglycemic agent used in the treatment of non-insulin-dependent diabetes mellitus not responding to dietary modification. Metformin improves glycemic control by improving insulin sensitivity and decreasing intestinal absorption of glucose. (From Martindale, The Extra Pharmacopoeia, 30th ed, p289)
metformin : A member of the class of guanidines that is biguanide the carrying two methyl substituents at position 1.
Cancer Pain: Pain that may be caused by or related to cellular, tissue, and systemic changes that occur during NEOPLASM growth, tissue invasion, and METASTASIS.
Excerpt | Relevance | Reference |
---|---|---|
"However, the function of aspirin use in pancreatic cancer largely remains unknown." | 2.53 | Aspirin in pancreatic cancer: chemopreventive effects and therapeutic potentials. ( Dai, JJ; Gu, DN; Huang, Q; Jiang, MJ; Tian, L, 2016) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Jiang, MJ | 1 |
Dai, JJ | 1 |
Gu, DN | 1 |
Huang, Q | 1 |
Tian, L | 1 |
1 review available for metformin and Cancer Pain
Article | Year |
---|---|
Aspirin in pancreatic cancer: chemopreventive effects and therapeutic potentials.
Topics: Animals; Anticarcinogenic Agents; Aspirin; Cancer Pain; Humans; Metformin; Pancreatic Neoplasms | 2016 |